Mercaptopurine for the Treatment of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC), Uterine/Cutaneous Leiomyomas, and Kidney Cancer

NCT07716735 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Advanced Kidney Carcinoma
Advanced Renal Cell Carcinoma
Hereditary Leiomyomatosis and Renal Cell Carcinoma
Metastatic Kidney Carcinoma
Metastatic Renal Cell Carcinoma
Skin Leiomyoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8
Uterine Corpus Leiomyoma

Interventions

PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Mercaptopurine
OTHER: Questionnaire Administration
PROCEDURE: Skin Biopsy

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]
[object Object]